Largest NASDAQ Biotechnology Companies

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Market Capitalization
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Market CapitalizationEfficiencyMarket RiskExp Return
1AZN AstraZeneca PLC ADR
219.58 B
(0.04)
 1.87 
(0.07)
2AMGN Amgen Inc
155.74 B
(0.05)
 1.86 
(0.10)
3GILD Gilead Sciences
134.97 B
 0.03 
 2.08 
 0.06 
4SNY Sanofi ADR
116.54 B
(0.09)
 1.86 
(0.16)
5VRTX Vertex Pharmaceuticals
115.15 B
(0.11)
 1.97 
(0.22)
6REGN Regeneron Pharmaceuticals
56.43 B
(0.09)
 3.70 
(0.34)
7ALNY Alnylam Pharmaceuticals
40.38 B
 0.05 
 3.20 
 0.15 
8ARGX argenx NV ADR
33.16 B
(0.06)
 2.60 
(0.15)
9BNTX BioNTech SE
25.61 B
 0.04 
 4.28 
 0.18 
10RPRX Royalty Pharma Plc
19.6 B
 0.04 
 1.70 
 0.08 
11INSM Insmed Inc
19.5 B
 0.11 
 4.57 
 0.50 
12BIIB Biogen Inc
18.61 B
(0.06)
 2.32 
(0.15)
13SMMT Summit Therapeutics PLC
15.27 B
 0.05 
 8.86 
 0.42 
14ILMN Illumina
14.32 B
 0.03 
 3.04 
 0.09 
15INCY Incyte
13.25 B
 0.08 
 2.09 
 0.16 
16UTHR United Therapeutics
13.11 B
(0.04)
 2.60 
(0.12)
17GMAB Genmab AS
13.09 B
 0.07 
 2.32 
 0.17 
18NBIX Neurocrine Biosciences
12.52 B
 0.07 
 2.66 
 0.18 
19TEM Tempus AI, Class
11.83 B
 0.07 
 6.65 
 0.45 
20EXEL Exelixis
11.01 B
 0.05 
 3.24 
 0.16 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares. In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY